Max Robotics — Global Service Robot Directory + US Certification

About

Jeremy Goad is a leading urological surgeon and researcher whose work has fundamentally shaped the modern management of prostate cancer, particularly through the advancement of robot-assisted surgery. His landmark 1996 study, "Risk Factors for Urinary Incontinence after Radical Prostatectomy," remains a cornerstone of the field with over 530 citations, providing critical insights into patient outcomes that continue to guide surgical decision-making. Goad has been instrumental in translating robotic surgical innovation into public health systems, as demonstrated by his influential 2015 health economic analysis of robot-assisted radical prostatectomy (RARP) in the Australian public system, which helped establish the viability and patterns of care for this technology. His commitment to improving patient experience is evident in the development of "Robocare," an innovative nurse-led care pathway for robotic prostatectomy patients. Over a 12-year period in Melbourne, Goad has tracked the evolving landscape of RARP, documenting shifts in disease presentation and surgical practice. His expertise extends to advanced laparoscopic techniques, including partial nephrectomy for renal tumors. With a career spanning from foundational outcomes research to health economics and novel care models, Goad’s work has had a lasting impact on how urological cancers are treated and managed.